BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2458158)

  • 1. Benign intracranial hypertension during chemotherapy for testicular teratoma.
    Marsh LF; Morgan DA; Jefferson D
    Br J Radiol; 1988 Aug; 61(728):692. PubMed ID: 2458158
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ; Williams JJ
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual masses after successful chemotherapy for testicular carcinoma.
    Glowalla M
    AJR Am J Roentgenol; 1986 Jun; 146(6):1184-6. PubMed ID: 3486562
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A; Peckham MJ
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
    Horwich A; Peckham MJ
    Cancer Treat Rep; 1986 Nov; 70(11):1329-31. PubMed ID: 2429765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced testicular seminoma--chemotherapy and serum marker].
    Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
    Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
    Fossa SD; Paus E
    Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
    [No Abstract]   [Full Text] [Related]  

  • 10. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
    Braunstein GD; McIntire KR; Waldmann TA
    Cancer; 1973 May; 31(5):1065-8. PubMed ID: 4122298
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis following chemotherapy for metastatic malignant teratoma.
    Horwich A; Easton D; Husband J; Nicholas D; Peckham MJ
    Br J Urol; 1987 Jun; 59(6):578-83. PubMed ID: 2446691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
    Hayashi M; Ebihara K; Urano E
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
    Lichinitser MR; Bassalyk LS; Levina DM; Pashintseva LP; Molodyk AA
    Ter Arkh; 1984; 56(6):77-9. PubMed ID: 6206585
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased.
    Tonkin KS; Rustin GJ; Wignall B; Paradinas F; Bennett M
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1739-43. PubMed ID: 2483686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HCG producing malignant teratoma of the testis: a rare cause of precocious isosexual maturation in boys].
    Kremens B; Hauffa BP; Metz K
    Monatsschr Kinderheilkd; 1990 Oct; 138(10):684-8. PubMed ID: 1706819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular tumors--a breakthrough?].
    Schmidt CG
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1293-300. PubMed ID: 6635628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-HCG producing seminoma.
    Fossa SD; Risberg T
    Prog Clin Biol Res; 1985; 203():105-6. PubMed ID: 2421322
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
    de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
    Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spermatic blood beta HCG levels in testicular tumors and in varicocele.
    Fiet J; Jardin A; Gourmel B; Villette JM; Guechot J; Gueux B
    Prog Clin Biol Res; 1985; 203():117-20. PubMed ID: 2421324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.